Sarepta Therapeutics
SRPT
SRPT
189 hedge funds and large institutions have $1.44B invested in Sarepta Therapeutics in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 77 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+10
Holders Change %
+5.59%
% of All Funds
4.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
33
Increased
77
Reduced
48
Closed
23
Calls
$145M
Puts
$74.3M
Net Calls
+$70.8M
Net Calls Change
+$17.3M
Top Buyers
| 1 |
Millennium Management
New York
|
+$41.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.2M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.3M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$18.5M |
| 5 |
HM
HealthCor Management
New York
|
+$16.2M |
Top Sellers
| 1 |
CC
Carlson Capital
Dallas,
Texas
|
-$54.6M |
| 2 |
O
OrbiMed
New York
|
-$31.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$23M |
| 4 |
PP
PDT Partners
New York
|
-$10M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$9.75M |
